Researchers are sometimes frustrated when a prospective drug proves effective in some patients, but not enough to justify giving it to everyone who has the condition it is intended to treat.
The beta-blocker drug bucindolol met that fate in 2001 when it was originally tested as a treatment for heart failure. Though it did help a [...]

Tags: beta blockers, bucindolol, heart failure, personalized medicine, pharmacogenomics

The latest indication that the medical establishment takes personalized medicine seriously – this week’s Journal of the American Medical Association is a special theme issue dedicated to genetics and genomics.
The journal points to the incredible pace of recent discoveries associating specific genetic markers to various diseases and conditions. It even adds a few new revelations [...]

Tags: 23andMe, American Medical Association, JAMA, personalized medicine